The Golgi Localization of GOLPH2 (GP73/GOLM1) is Determined by the Transmembrane and Cytoplamic Sequences
Overview
Authors
Affiliations
Golgi phosphoprotein 2 (GOLPH2) is a resident Golgi type-II membrane protein upregulated in liver disease. Given that GOLPH2 traffics through endosomes and can be secreted into the circulation, it is a promising serum marker for liver diseases. The structure of GOLPH2 and the functions of its different protein domains are not known. In the current study, we investigated the structural determinants for Golgi localization using a panel of GOLPH2 truncation mutants. The Golgi localization of GOLPH2 was not affected by the deletion of the C-terminal part of the protein. A truncated mutant containing the N-terminal portion (the cytoplasmic tail and transmembrane domain (TMD)) localized to the Golgi. Sequential deletion analysis of the N-terminal indicated that the TMD with a positively charged residue in the cytoplasmic N-terminal tail were sufficient to support Golgi localization. We also showed that both endogenous and secreted GOLPH2 exist as a disulfide-bonded dimer, and the coiled-coil domain was sufficient for dimerization. This structural knowledge is important for the understanding the pathogenic role of GOLPH2 in liver diseases, and the development of GOLPH2-based hepatocellular cancer diagnostic methods.
Current status and new directions for hepatocellular carcinoma diagnosis.
Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R Liver Res. 2025; 8(4):218-236.
PMID: 39958920 PMC: 11771281. DOI: 10.1016/j.livres.2024.12.001.
Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment.
Feng P, Hu X, Zhou S, Liu X, Zeng L, Liu Y Front Immunol. 2025; 15():1508034.
PMID: 39845976 PMC: 11750648. DOI: 10.3389/fimmu.2024.1508034.
GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacy.
Liu J, Feng C, Zhao R, Song H, Huang L, Jiang N J Immunother Cancer. 2025; 13(1).
PMID: 39762082 PMC: 11749480. DOI: 10.1136/jitc-2024-009265.
Yan G, Zhu T, Zhou J, Li X, Wen Z, Miuhuitijiang B J Cell Mol Med. 2024; 28(20):e70186.
PMID: 39470578 PMC: 11520440. DOI: 10.1111/jcmm.70186.
Li S, Meng X, Zhang Y, Chen C, Jiao Y, Zhu Y Front Pharmacol. 2024; 14:1339518.
PMID: 38269286 PMC: 10806205. DOI: 10.3389/fphar.2023.1339518.